寨卡病毒风险与临床实践中的妊娠:疫情演变中的持续经验
美国一家围产中心2016年1月至8月开展纵向观察研究,纳入185名有寨卡病毒暴露风险的孕妇,按当时美国疾病控制与预防中心(CDC)指南提供检测。5名(3%)孕妇产前超声见提示胎儿寨卡病毒感染的表现,但病毒检测均阴性;153次筛查中8次(5%)免疫球蛋白M阳性或不确定,仅1例确诊;185人中1人(0.5%)确诊寨卡病毒感染,无确诊胎儿或新生儿感染。
要点
- 185名有寨卡暴露风险的孕妇中,1人(0.5%)确诊感染,无确诊胎儿或新生儿感染。
- 5名(3%)孕妇产前超声见小头畸形、心内强回声灶、脑室钙化等提示表现,病毒检测均阴性。
- 153次筛查中8次(5%)免疫球蛋白M阳性或不确定,仅1例经确证试验阳性。
核心结论
- 本队列中孕妇寨卡病毒确诊感染率低,但接诊人数反映患者和医生对围产期寨卡病毒感染的担忧程度,也提示医务人员需准备回答相关问题、解释实验室和超声结果并说明检测选择。
研究设计与样本
- 这是一项经机构审查委员会批准的纵向观察研究,2016年1月至8月在一家美国围产转诊中心开展,纳入曾前往或与曾前往有本地寨卡病毒传播记录地区者发生性接触的孕妇,共评估185名有潜在寨卡病毒暴露的孕妇。
- 检测按咨询就诊时生效版本的美国疾病控制与预防中心(CDC)指南提供。
主要发现
- 潜在暴露地区以墨西哥(44%)、加勒比(17%)、北美(16%)、南美(13%)和中美洲(9%)最常见。
- 123名(67%)患者报告昆虫叮咬,19名(10%)报告症状。
- 5名(3%)患者产前超声见提示可能胎儿寨卡病毒感染的表现,包括小头畸形、心内强回声灶和脑室钙化,其寨卡病毒检测结果均阴性。
- 153次寨卡病毒筛查检测中,8次(5%)免疫球蛋白M结果为阳性或不确定,仅1次经确证试验阳性。
- 185名受咨询者中1名(0.5%)、153名受检者中1名(0.7%)确诊寨卡病毒感染,无确诊胎儿或新生儿感染。
关键数值与推荐
- 检测按咨询就诊时生效版本的美国疾病控制与预防中心(CDC)指南提供,原文未列出具体推荐条款。
临床怎么用
- 作者指出,本队列孕妇寨卡病毒确诊感染率低,但接诊人数显示患者和医生对围产期寨卡病毒感染的担忧程度,并强调医务人员需准备回答相关问题、解释实验室和超声结果、说明检测选择。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe a single U.S. perinatal center's ongoing experience with evaluating pregnant patients with potential exposure to Zika virus infection. METHODS: This is an institutional review board-approved longitudinal observational study from January to August 2016 from a single perinatal referral center. Patients who had traveled to or had sexual contact with a person who traveled to a region with documented local Zika virus transmission were included in the study. The aim of the study was to identify the rate of confirmed infection among pregnant women referred to our center with established risk factors for Zika virus acquisition. We also sought to characterize travel patterns that constituted risk, to identify rates of symptoms suggesting infection, and to potentially describe findings suggestive of congenital Zika virus infection in prenatal ultrasound evaluations. RESULTS: We evaluated 185 pregnant women with potential Zika virus exposure. Testing was offered in accordance with the version of the Centers for Disease Control and Prevention guidelines in place at the time of the consultation visit. Geographic exposure data showed Mexico (44%), the Caribbean (17%), North America (16%), South America (13%), and Central America (9%) to be the most common areas in which potential exposure occurred. One hundred twenty-three (67%) patients reported insect bites and 19 (10%) patients reported symptoms. Overall, five (3% of all) patients had prenatal ultrasound findings suggestive of possible fetal Zika virus infection; all their Zika virus test results returned negative. These findings included microcephaly, echogenic intracardiac foci, and ventricular calcifications. Of the 153 Zika virus screening tests ordered, eight (5%) immunoglobulin M results returned positive or equivocal with only one positive through confirmatory testing. Overall, 1 of 185 (0.5%) of all those consulted and 1 of 153 (0.7%) of those tested had a confirmed Zika virus infection with no confirmed fetal or neonatal infections. CONCLUSION: We identified low rates of confirmed maternal Zika virus infection in our cohort, but the number of patients described here demonstrates the magnitude of concern existing among both patients and physicians regarding possible perinatal Zika virus infection. It also underscores the need for health care providers to be prepared to answer questions, explain laboratory and ultrasound results, and describe testing options for concerned patients and their families.
引用
- Rao R, Gaw SL, Han CS, et al. Zika Risk and Pregnancy in Clinical Practice: Ongoing Experience as the Outbreak Evolves. Obstet Gynecol. 2017. PMID: 28486369. doi:10.1097/AOG.0000000000002049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。